Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective
S Finocchario-Kessler, C Wexler, M Maloba… - BMC women's …, 2016 - Springer
Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …
cancer. Research and investment to improve vaccination, screening, and treatment efforts …
VALGENT: a protocol for clinical validation of human papillomavirus assays
Background Testing for high-risk HPV is more effective in primary cervical cancer screening
than the cytological examination of a Pap smear. Separate genotyping may be useful for …
than the cytological examination of a Pap smear. Separate genotyping may be useful for …
Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post …
SM Garland, J Paavonen, U Jaisamrarn… - … journal of cancer, 2016 - Wiley Online Library
We evaluated the efficacy of the human papillomavirus (HPV)− 16/18 AS04‐adjuvanted
vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc …
vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc …
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
S Boussios, E Seraj, G Zarkavelis, D Petrakis… - Critical reviews in …, 2016 - Elsevier
Background Cervical cancer is the fourth most common cancer affecting women worldwide.
Despite advances in screening and human papillomavirus (HPV) vaccination, a significant …
Despite advances in screening and human papillomavirus (HPV) vaccination, a significant …
[HTML][HTML] Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory
Z Zeng, H Yang, Z Li, X He, CC Griffith, X Chen… - Journal of …, 2016 - ncbi.nlm.nih.gov
Introduction: The prevalence of cervical Human Papillomavirus (HPV) infection varies
greatly worldwide and data regarding HPV prevalence and genotypes in China are limited …
greatly worldwide and data regarding HPV prevalence and genotypes in China are limited …
Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa
GM Clifford, H de Vuyst, V Tenet… - JAIDS Journal of …, 2016 - journals.lww.com
Objectives: HIV infection is known to worsen the outcome of cervical human papillomavirus
(HPV) infection and may do so differentially by HPV type. Design: Twenty-one studies were …
(HPV) infection and may do so differentially by HPV type. Design: Twenty-one studies were …
Mechanistic signatures of HPV insertions in cervical carcinomas
A Holmes, S Lameiras, E Jeannot, Y Marie… - NPJ genomic …, 2016 - nature.com
To identify new personal biomarkers for the improved diagnosis, prognosis and biological
follow-up of human papillomavirus (HPV)-associated carcinomas, we developed a generic …
follow-up of human papillomavirus (HPV)-associated carcinomas, we developed a generic …
[HTML][HTML] Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes
D Mesher, K Soldan, M Lehtinen… - Emerging infectious …, 2016 - ncbi.nlm.nih.gov
We analyzed human papillomavirus (HPV) prevalences during prevaccination and
postvaccination periods to consider possible changes in nonvaccine HPV genotypes after …
postvaccination periods to consider possible changes in nonvaccine HPV genotypes after …
[HTML][HTML] Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology
Y Liu, Z Lu, R Xu, Y Ke - Oncotarget, 2016 - ncbi.nlm.nih.gov
Integration of human papillomavirus (HPV) DNA into the host genome can be a driver
mutation in cervical carcinoma. Identification of HPV integration at base resolution has been …
mutation in cervical carcinoma. Identification of HPV integration at base resolution has been …
Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study
D Mesher, K Panwar, SL Thomas, S Beddows… - BMJ open, 2016 - bmjopen.bmj.com
Objectives The human papillomavirus (HPV) immunisation programme in England was
introduced in 2008. Monitoring changes in type-specific HPV prevalence allows assessment …
introduced in 2008. Monitoring changes in type-specific HPV prevalence allows assessment …